Immunochemotherapy of malignant glioma: synergistic activity of CD95 ligand and chemotherapeutics. (Record no. 9093272)

MARC details
000 -LEADER
fixed length control field 01342 a2200373 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250513114653.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 199705s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 0340-7004
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1007/s002620050355
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Roth, W
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 19970509
245 00 - TITLE STATEMENT
Title Immunochemotherapy of malignant glioma: synergistic activity of CD95 ligand and chemotherapeutics.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Cancer immunology, immunotherapy : CII
Date of publication, distribution, etc. Mar 1997
300 ## - PHYSICAL DESCRIPTION
Extent 55-63 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article; Research Support, Non-U.S. Gov't
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antineoplastic Agents
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Apoptosis
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Brain Neoplasms
General subdivision therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Combined Modality Therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Glioma
General subdivision therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Proto-Oncogene Proteins c-bcl-2
General subdivision metabolism
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Tumor Cells, Cultured
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Tumor Suppressor Protein p53
General subdivision metabolism
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element fas Receptor
General subdivision therapeutic use
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Fontana, A
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Trepel, M
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Reed, J C
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Dichgans, J
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Weller, M
773 0# - HOST ITEM ENTRY
Title Cancer immunology, immunotherapy : CII
Related parts vol. 44
-- no. 1
-- p. 55-63
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1007/s002620050355">https://doi.org/10.1007/s002620050355</a>
Public note Available from publisher's website

No items available.